Things For Investors To Watch In Tandem Diabetes Care Inc (NASDAQ: TNDM)

money audit

Tandem Diabetes Care Inc (NASDAQ:TNDM) does about 1.57M shares in volume on a normal day but saw 1899587 shares change hands in Monday trading. The company now has a market cap of 3.13B USD. Its current market price is $48.50, marking a decrease of -0.72% compared to the previous close of $48.85. The 52 week high reached by this stock is $53.69 whilst the lowest price level in 52 weeks is $13.82.

Tandem Diabetes Care Inc (TNDM) has a 20-day trading average at $49.52 and the current price is -9.67% off the 52-week high compared with 250.94% distance from its 52-week low. The 50-day simple moving average of the closing price is $41.38 and its 200-day simple moving average is $28.17. If we look at the stock’s price movements over the week, volatility stands at 5.07%, which decreases to 4.71% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 54.09 to suggest the stock is neutral.

The consensus objective for the share price is $51.67, suggesting that the stock has a potential upside of 6.14% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 30, 2024 when Redburn Atlantic initiated the stock to “Buy” and issued a price target of $60. Citigroup upgraded the stock to “Buy” from Neutral on May 22, 2024 at a price target of $40-$57. Wells Fargo upgraded its price target at $21-$45.

Tandem Diabetes Care Inc (TNDM) stock is down -6.69% over the week and 10.10% over the past month. Its price is 63.96% year-to-date and 100.58% over the past year.

To reach the target analysts have set, the stock logically needs to grow 6.14 percent from here.

The company has a return on investment of -20.11% and return on equity of -48.62%. The beta has a value of 1.32. Price to book ratio is 12.88 and price to sales ratio is 4.07.